B Autran
Overview
Explore the profile of B Autran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
2902
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Autran B
Rev Mal Respir
. 2019 Sep;
36(9):1047-1056.
PMID: 31522947
The aging population raises a number of public health issues including a need to address the severity and frequency of infections observed in older people. Vaccines play an important role...
2.
Lavole A, Guihot A, Veyri M, Lambotte O, Autran B, Cloarec N, et al.
Ann Oncol
. 2018 Jan;
29(4):1065-1066.
PMID: 29346600
No abstract available.
3.
Bendenoun M, Samri A, Avettand-Fenoel V, Cardinaud S, Descours B, Carcelain G, et al.
EBioMedicine
. 2017 Dec;
27:51-60.
PMID: 29273355
Background: We describe a homosexual man who strongly controlled HIV-1 for ten years despite lack of protective genetic background. Methods: HIV-1 DNA was measured in blood and other tissues. Cell...
4.
Guihot A, Marcelin A, Massiani M, Samri A, Soulie C, Autran B, et al.
Ann Oncol
. 2017 Dec;
29(2):517-518.
PMID: 29206889
No abstract available.
5.
Guihot A, Cadranel J, Lambotte O, Lavole A, Autran B, Spano J
Rev Mal Respir
. 2016 May;
33(6):419-21.
PMID: 27140903
No abstract available.
6.
Spano J, Poizot-Martin I, Costagliola D, Boue F, Rosmorduc O, Lavole A, et al.
Ann Oncol
. 2015 Dec;
27(3):397-408.
PMID: 26681686
Malignancies represent a major cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral therapy has modified the spectrum of malignancies in HIV infection...
7.
Hattab S, Guiguet M, Carcelain G, Fourati S, Guihot A, Autran B, et al.
HIV Med
. 2015 May;
16(9):553-62.
PMID: 25944318
Objectives: The aim of the study was to assess the impact of rapid and sustained viral control produced by combination antiretroviral therapy (cART) on HIV-associated immune activation and inflammation. Methods:...
8.
Guergnon J, Dalmasso C, Broet P, Meyer L, Westrop S, Imami N, et al.
J Infect Dis
. 2012 Jan;
205(5):718-24.
PMID: 22238471
We performed a genome-wide association study comparing a cohort of 144 human immunodeficiency virus (HIV type 1-infected, untreated white long-term nonprogressors (LTNPs) with a cohort of 605 HIV-1-infected white seroconverters....
9.
Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong D, et al.
Arthritis Rheum
. 2011 Aug;
63(11):3502-11.
PMID: 21811996
Objective: To assess the factors influencing the efficacy of 2 injections of a pandemic 2009 influenza A (H1N1) vaccine in patients with systemic lupus erythematosus (SLE). Methods: We conducted a...
10.
Simonney N, Dewulf G, Herrmann J, Gutierrez M, Vicaut E, Boutron C, et al.
Tuberculosis (Edinb)
. 2008 May;
88(5):453-61.
PMID: 18495539
A prospective and multi-centre study has allowed us to analyse antibody responses and Mycobacterium tuberculosis clinical isolate genotypes on 24 consecutive HIV-TB co-infected patients treated with Highly Active Antiretroviral Therapy...